A phase I study of BI 853520, an inhibitor of focal adhesion kinase (FAK), in patients with advanced or metastatic solid tumors. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Zer, Alona
  • Verheijen, Remy
  • De Vos, Filip Yves Francine Leon
  • Hotte, Sebastien
  • Eskens, Ferry
  • Pronk, Linda
  • Siu, Lillian L
  • Schnell, David
  • Steeghs, Neeltje
  • Langenberg, Marlies HG
  • Hirte, Hal
  • De Jonge, Maja J

publication date

  • May 20, 2015